|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_on1363835113 |
| 003 |
OCoLC |
| 005 |
20231120010722.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
221031s2023 ne fob 001 0 eng d |
| 040 |
|
|
|a UKAHL
|b eng
|e rda
|c UKAHL
|d OPELS
|d EBLCP
|d YDX
|d OCLCF
|d N$T
|d OCLCQ
|d UKMGB
|d YUS
|d OCLCA
|d OCL
|d OCLCQ
|d OCLCO
|
| 015 |
|
|
|a GBC2K2065
|2 bnb
|
| 016 |
7 |
|
|a 020802894
|2 Uk
|
| 019 |
|
|
|a 1374585714
|
| 020 |
|
|
|a 0323913792
|q electronic book
|
| 020 |
|
|
|a 9780323913799
|q (electronic bk.)
|
| 020 |
|
|
|z 9780323999243
|q paperback
|
| 035 |
|
|
|a (OCoLC)1363835113
|z (OCoLC)1374585714
|
| 050 |
|
4 |
|a QP171
|b .M48 2023
|
| 082 |
0 |
4 |
|a 612.39
|2 23
|
| 245 |
0 |
0 |
|a Metabolomics :
|b a path towards personalized medicine /
|c edited by Mahbuba Rahman.
|
| 264 |
|
1 |
|a London ;
|a San Diego, CA :
|b Academic Press, an imprint of Elsevier,
|c [2023]
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
0 |
|
|a Developments in applied microbiology and biotechnology
|
| 500 |
|
|
|a Includes index.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Chapter 1 Personalized medicine; 1.1 Introduction and historical perspective; 1.2 Conventional medicine vs. personalized medicine; 1.3 Enabling technologies; 1.4 The potential of personalized medicine; 1.5 Implementing personalized medicine in clinical practice: Policies, regulation, support, and challenges; 1.6 The cost-effectiveness of personalized medicine; 1.7 The future of personalized medicine -- Chapter 2 Metabolomics for personalized medicine; 2.1 Introduction; 2.2 Technological platforms to measure metabolites; 2.3 Metabolomic workflow for personalized medicine; 2.4 Current challenges of metabolomics for personalized medicine; 2.5 Conclusion -- Chapter 3 Metabolomics in clinical diagnosis, prognosis, and treatment of infectious diseases; 3.1 Introduction; 3.2 Metabolomics analytical approaches in infectious diseases; 3.3 Metabolomics in diagnosis, prognosis, and management; 3.4 Metabolomics for treatment strategy of infectious diseases; 3.5 Conclusions and future perspectives -- Chapter 4 Metabolomics used in clinical diagnosis related to newborn screening; 4.1 Introduction; 4.2 Diagnosis and screening of newborn disorders; 4.3 Newborn disorders; 4.4 Management and treatment of IEM; 4.5 Current challenges with newborn genomic screening (NBGS); 4.6 Potential solution for NBGS; 4.7 Conclusion -- Chapter 5 Metabolic biomarkers in cancer; 5.1 Introduction; 5.2 Leukemia cancer; 5.3 Ovarian cancer; 5.4 Lung cancer; 5.5 Breast cancer; 5.6 Liver cancer; 5.7 Cancer cachexia; 5.8 Summary; Acknowledgments -- Chapter 6 Magnetic resonance imaging in personalized medicine; 6.1 Introduction; 6.2 Magnetic resonance imaging; 6.3 Nanoparticle in magnetic resonance imaging; 6.4 Theranostic use of nanoparticles in diseases; 6.5 Conclusion -- Chapter 7 Metabolomics of diabetes and cardiovascular disease; 7.1 Introduction; 7.2 Metabolomics; 7.3 Techniques for metabolites detection; 7.4 Workflow for metabolomics; 7.5 Metabolomics in biomarker identification; 7.6 Current challenges; 7.7 Conclusion -- Chapter 8 Industrial application of metabolomics for personalized medicine: Current status and challenges; 8.1 Introduction; 8.2 Global market for personalized medicine; 8.3 Instruments contributing to personalized medicine; 8.4 Metabolic biomarkers and therapeutics; 8.5 Diagnostics; 8.6 Challenges at industrial levels for personalized medicine; 8.7 Conclusion
|
| 588 |
|
|
|a Description based on online resource; title from digital title page (viewed on March 16, 2023).
|
| 650 |
|
0 |
|a Metabolism.
|
| 650 |
|
0 |
|a Metabolites.
|
| 650 |
|
0 |
|a Precision medicine.
|
| 650 |
|
2 |
|a Precision Medicine
|0 (DNLM)D057285
|
| 650 |
|
6 |
|a M�etabolites.
|0 (CaQQLa)201-0030193
|
| 650 |
|
6 |
|a M�edecine de pr�ecision.
|0 (CaQQLa)000288678
|
| 650 |
|
7 |
|a Metabolism
|2 fast
|0 (OCoLC)fst01017473
|
| 650 |
|
7 |
|a Metabolites
|2 fast
|0 (OCoLC)fst01017507
|
| 650 |
|
7 |
|a Precision medicine
|2 fast
|0 (OCoLC)fst01910010
|
| 655 |
|
0 |
|a Electronic books.
|
| 700 |
1 |
|
|a Rahman, Mahbuba,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Metabolomics
|z 9780323999243
|w (OCoLC)1350641001
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780323999243
|z Texto completo
|
